Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

Be Sun Smart During UV Safety Awareness Month

July 13th 2018

July is UV Safety Awareness Month. See three tips on how to protect yourself from harmful UV rays, which are the leading cause of skin cancer.

Cancer Rates 'Soar' in Flight Crew Compared with General Population

July 4th 2018

While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.

FDA Approves Drug Duo for BRAF-Positive Melanoma

June 27th 2018

The FDA has approved the combination of the BRAF inhibitor Braftovi (encorafenib) and the MEK inhibitor Mektovi (binimetinib) for the treatment of patients with BRAF-mutant unresectable or metastatic melanoma, as detected by an FDA-approved test.

Keytruda Granted sBLA for Melanoma Treatment

June 25th 2018

The FDA has accepted a supplemental biologics license application (sBLA) for the use of Keytruda (pembrolizumab) as an adjuvant treatment for patients with resected, high-risk stage 3 melanoma, according to Merck (MSD), the manufacturer of the PD-1 inhibitor.

It Takes Two

June 22nd 2018

In melanoma, combining two immunotherapies may lower costs and improve quality of life.

New Therapies Are Gathering Speed

June 21st 2018

Novel immunotherapies either release the immune system’s parking brake or hit its gas pedal.

Contagious Enthusiasm

June 20th 2018

Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

The Jury Is Out

June 19th 2018

Checkpoint inhibitors can be extremely effective for the right patients, but identifying who will benefit remains an imprecise science.

Under New Management

June 19th 2018

A new expert guideline for managing immunotherapy’s side effects has been released.

Men Who Take Daily Aspirin at Higher Risk for Melanoma

June 15th 2018

Study findings published in the Journal of the American Academy of Dermatology showed that once-daily aspirin use can increase the risk of melanoma in men — nearly double that of men who do not use aspirin each day.

Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors

June 14th 2018

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

Immunotherapy Outcomes May Be Better in Older Patients With Melanoma

June 14th 2018

Age shouldn't be a determining factor in giving a patient with melanoma immunotherapy. In fact, one study found that older patients actually do better on checkpoint blockades.

Keep Hope: It's OK to Cry While Celebrating or Celebrate While Crying

June 11th 2018

Recognize birthdays, but most importantly, keep hope, says a breast cancer and melanoma survivor.

Larotrectinib Granted Priority Review for NTRK-Positive Cancers

May 29th 2018

The FDA has granted a priority review to a new drug application (NDA) for larotrectinib for the treatment of adult and pediatric patients with locally advanced or metastatic solid tumors with an NTRK gene fusion, according to Bayer and Loxo Oncology, the codevelopers of the pan-TRK inhibitor.

Patients and Caregivers Are on the 'Frontline' of Melanoma Monitoring

May 22nd 2018

Recent research, conducted at NYU Langone Health and presented at the Oncology Nursing Society (ONS) Annual Congress, sought to find out how patients with melanoma perceived skin health education, and their willingness be involved in their own surveillance or a loved one’s.

Skin Cancer Awareness Month from a Melanoma Survivor's Perspective

May 22nd 2018

One melanoma survivor offers advice for Skin Cancer Awareness Month.

Running, Stumbling and Finding the Way through Cancer

May 4th 2018

I think being an athlete is what saved my life.

The Melanoma Effect

May 4th 2018

If I ever got sick or injured I would go to the children’s hospital, but that was nothing like a real hospital where people are fighting for their life day-in and day-out. I absolutely hated it, and still do. I was in Emory Hospital visiting my dad two to three times a week for about six months, and every time I walked in that place, it just gave me the heebie-jeebies.

Your Cancer Game Plan

May 3rd 2018

Mike Schmidt developed stage 3 melanoma after years of playing professional baseball for the Philadelphia Phillies.

Dermatology Checkups After Breast Cancer

May 2nd 2018

After radiation, as the skin heals, a compassionate dermatologist can help us to monitor any lingering side-effects.

FDA Approves Combination for Adjuvant Treatment of Melanoma Subtypes

May 1st 2018

The combination therapy of Tafinlar (dabrafenib) and Mekinist (trametinib) was granted Food and Drug Administration (FDA) approval for the treatment of patients with BRAF V600E– or V600K–positive stage 3 melanoma following complete resection.

Spring Is Here, and So is Skin Cancer Awareness Month

April 30th 2018

May is skin cancer awareness month, and a good reminder to schedule an appointment with your dermatologist.

Older Patients with Metastatic Melanoma May Benefit from Immunotherapy

April 25th 2018

Age should not limit which patients with metastatic melanoma receive immunotherapy.

Pre-Surgical Immunotherapy Identifies Potential Benefit, Risk of Recurrence in Melanoma

April 19th 2018

For patients with melanoma, administration of a PD-1 checkpoint blockade therapy in the neoadjuvant setting – meaning it was given before the main treatment – could result in improved outcomes and better insight to patient responses.

Tissue of Origin Test Results May Have Treatment Implications

April 16th 2018

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

Cancer Was Not a Gift, But We Can Use it as an Opportunity

March 27th 2018

"I have grown as a person since becoming a cancer survivor," says breast cancer and melanoma survivor Barbara Tako.

Patient Education Key in Flexible Dosing Schedule for Opdivo

March 22nd 2018

After a recent FDA approval for an additional dosing schedule option for Opdivo, patients must be educated on the potential side effects that may occur between prolonged visits.

Unmet Needs After Uveal Melanoma Diagnosis Make Patients Yearn to Learn More

March 21st 2018

A recent study conducted at UCLA showed that nearly all patients with uveal melanoma reported having unmet psychologic and informational needs, especially in the few months following their diagnosis.

I Am Sorry for Being a Bad Cancer Role Model

March 6th 2018

Breast cancer survivors says that even though cancer is big, scary and demanding, it never justifies bad behavior as a person.

Patients Now Have the Option to Undergo Immunotherapy Less Frequently

March 6th 2018

The Food and Drug Administration (FDA) has approved a supplemental biologics license application adding a four-week dosing schedule for Opdivo (nivolumab) across several of the PD-1 inhibitor’s indications.